Chiara Vantaggiato
Via D. L. Monza 20, Lecco
Bosisio Parini, 23842, Italy
Bosisio Parini, 23842, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Apoptosis and motor deficits in SPG76 hereditary spastic paraplegia: Calpain 2 inhibition as therapeutic strategy.
Journal: Pharmacological research
Published: December 18, 2025
Wings of Discovery: Using Drosophila to Decode Hereditary Spastic Paraplegia and Ataxias.
Journal: Cells
Published: July 28, 2025
Naringenin and SMER28 target lysosomal reformation and rescue SPG11 and SPG15 hereditary spastic paraplegia phenotypes.
Journal: Pharmacological research
Published: January 14, 2025
Further evidence supporting the role of GTDC1 in glycine metabolism and neurodevelopmental disorders.
Journal: European journal of human genetics : EJHG
Published: November 29, 2023
Estimation of the reference values and decision limits for growth hormone in newborns using dried blood spots.
Journal: Clinical chemistry and laboratory medicine
Published: September 03, 2023
Extensive analytical evaluation of the performances of the new DiaSys PCT assay and comparison with Elecsys B·R·A·H·M·S PCT test on Roche Cobas and B·R·A·H·M·S PCT-sensitive Kryptor.
Journal: Clinical chemistry and laboratory medicine
Published: February 25, 2023
Olanzapine, risperidone and ziprasidone differently affect lysosomal function and autophagy, reflecting their different metabolic risk in patients.
Journal: Translational psychiatry
Published: January 18, 2023
Simplexviruses Successfully Adapt to Their Host by Fine-Tuning Immune Responses.
Journal: Molecular biology and evolution
Published: June 22, 2022
Rescue of lysosomal function as therapeutic strategy for SPG15 hereditary spastic paraplegia.
Journal: Brain : a journal of neurology
Published: March 23, 2022
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects.
Journal: Cardiovascular research
Published: December 29, 2021
Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy.
Journal: Pharmacological research
Published: April 12, 2021
Last Updated: 09/26/2026